Abstract:Background: mTORC1 recruits its substrate 4E-BP1 via Raptor/4E-BP1 interaction. Chemical cross-linking/mass spectrometry permits characterization of protein-protein interactions. Results: Cross-linked peptides between Raptor and 4E-BP1 were identified. Raptor intramolecular cross-links were also identified. Conclusion: Raptor N-terminal region containing RNC1 is implicated in the interaction with the central region of 4E-BP1. Significance: Our study provides novel insight into how mTORC1 recognizes 4E-BP1.mTORC1 plays critical roles in the regulation of protein synthesis, growth, and proliferation in response to nutrients, growth factors, and energy conditions. One of the substrates of mTORC1 is 4E-BP1, whose phosphorylation by mTORC1 reverses its inhibitory action on eIF4E, resulting in the promotion of protein synthesis. Raptor in mTOR complex 1 is believed to recruit 4E-BP1, facilitating phosphorylation of 4E-BP1 by the kinase mTOR. We applied chemical cross-linking coupled with mass spectrometry analysis to gain insight into interactions between mTORC1 and 4E-BP1. Using the cross-linking reagent bis[sulfosuccinimidyl] suberate, we showed that Raptor can be cross-linked with 4E-BP1. Mass spectrometric analysis of cross-linked Raptor-4E-BP1 led to the identification of several cross-linked peptide pairs. Compilation of these peptides revealed that the most N-terminal Raptor N-terminal conserved domain (in particular residues from 89 to 180) of Raptor is the major site of interaction with 4E-BP1. On 4E-BP1, we found that cross-links with Raptor were clustered in the central region (amino acid residues 56-72) we call RCR (Raptor cross-linking region). Intramolecular cross-links of Raptor suggest the presence of two structured regions of Raptor: one in the N-terminal region and the other in the C-terminal region. In support of the idea that the Raptor N-terminal conserved domain and the 4E-BP1 central region are closely located, we found that peptides that encompass the RCR of 4E-BP1 inhibit cross-linking and interaction of 4E-BP1 with Raptor. Furthermore, mutations of residues in the RCR decrease the ability of 4E-BP1 to serve as a substrate for mTORC1 in vitro and in vivo.

4E-BP1, a multifactor regulated multifunctional protein

Eif4e Binding Protein 1 Expression is Associated with Clinical Survival Outcomes in Colorectal Cancer

Mtor/4e‐bp1 Pathway is a Translational Regulator of Prostate Cancer Progression

mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3 -mediated non-degradative ubiquitination of eIF4A1

Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers

eIF4A1 enhances LARP1-mediated translational repression during mTORC1 inhibition

mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3 IBTK -mediated ubiquitination of eIF4A1 in cancer cells

Mtorc1/s6k1 Signaling Promotes Sustained Oncogenic Translation Through Modulating CRL3IBTK-mediated Non-Degradative Ubiquitination of Eif4a1

Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer

The human eIF4E:4E-BP2 complex structure for studying hyperphosphorylation

Eukaryotic translation initiation factor 4A1 in the pathogenesis and treatment of cancers

Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma

Translational Regulator Eif2α in Tumor

Functional analogs of mammalian 4E-BPs reveal a role for TOR in global plant translation

Distinct roles of LARP1 and 4EBP1/2 in regulating translation and stability of 5′TOP mRNAs

Eukaryotic initiation factor 4B is a multi-functional RNA binding protein that regulates histone mRNAs

Phosphoproteome Profiling Revealed The Importance Of Mtor Inhibition On Cdk1 Activation To Further Regulate Cell Cycle Progression

The Translational Regulation in mTOR Pathway

Characterization of the Raptor/4E-BP1 Interaction by Chemical Cross-Linking Coupled with Mass Spectrometry Analysis.

Phospho-eIF4E: a New Target for Acute Myeloid Leukemia.

Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy